These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24930084)

  • 1. [Vasoactive and inotropic drugs in acute heart failure].
    Ruiz-Laiglesia FJ; Camafort-Babkowski M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
    Heywood JT; Khan TA
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH
    Coron Artery Dis; 1994 Feb; 5(2):119-26. PubMed ID: 8180743
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of intravenous vasodilators in acute heart failure management.
    Piper S; McDonagh T
    Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
    Chatterjee K; De Marco T
    Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The year in cardiology: heart failure 2014.
    Voors AA; Ruschitzka F
    Eur Heart J; 2015 Feb; 36(7):421-4. PubMed ID: 25575601
    [No Abstract]   [Full Text] [Related]  

  • 8. [New inotropic drugs].
    Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R
    G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
    Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
    Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathomimetics, inotropics, and vasodilators.
    Clements JV
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):395-408. PubMed ID: 1576037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].
    Rohde LE; Ribeiro JP
    Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of inotropic agents.
    Vroom MB
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
    Colbert K; Greene MH
    Crit Care Nurs Q; 2003; 26(1):40-4. PubMed ID: 12669946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs in the treatment of heart failure.
    Brown L
    Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):829-32. PubMed ID: 8593738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction.
    Murtaza G; Siddiqui A; Hussain I
    Curr Protein Pept Sci; 2018; 19(11):1079-1087. PubMed ID: 29984650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The failing heart and the hemodynamic response to vasodilator therapy.
    Mills RM
    Clin Cardiol; 2003 Jun; 26(6):257-8. PubMed ID: 12839041
    [No Abstract]   [Full Text] [Related]  

  • 19. New positive inotropic agents.
    Jafri SM; Bristol JA
    Henry Ford Hosp Med J; 1986; 34(3):188-92. PubMed ID: 3542907
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.